Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress

被引:79
作者
Pleiner, J
Mittermayer, F
Schaller, G
Marsik, C
MacAllister, RJ
Wolzt, M
机构
[1] UCL, Dept Med, Ctr Clin Pharmacol & Therapeut, London, England
[2] Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
关键词
D O I
10.1016/j.jacc.2003.06.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We sought to determine the role of oxidative stress in the development of vascular dysfunction in inflammation. BACKGROUND Hyporeactivity to catecholamines and other vasoconstrictors is present in acute inflammation. Because oxidative stress plays a significant role in inflammation, impaired responsiveness may be overcome by anti-oxidants. METHODS In randomized, double-blind, cross-over studies, forearm blood flow (FBF) responses to norepinephrine (NE), angiotensin II (ANG II), and vasopressin (VP) were assessed before and 4 h after induction of systemic inflammation by low doses of Escherichia coli endotoxin (lipopolysaccharide [LPS], 20 IU/kg intravenously) or after placebo in healthy volunteers. Furthermore, the effect of intra-arterial vitamin C (24 mg/min) or placebo on NE-induced or ANG II-induced vasoconstriction was studied after LPS. RESULTS Administration of LPS caused systemic and forearm vasodilation, increased white blood cell count, elevated body temperature, and reduced vitamin C plasma concentrations. Lipopolysaccharide decreased the responses of FBF to NE by 59%, to ANG II by 25%, and to VP by 51% (n = 9, p < 0.05, all effects). Co-administration of vitamin C completely restored the response to NE and to ANG II, which was comparable to that observed under baseline conditions (n = 8). CONCLUSIONS E. coli-endotoxemia reduces FBF responsiveness to vasoconstrictors. The hyporeactivity can be corrected by high doses of vitamin C, suggesting that oxidative stress may represent an important target for inflammation-induced impaired vascular function. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:1656 / 1662
页数:7
相关论文
共 37 条
[1]   Compartmentalised inducible nitric-oxide synthase activity in septic shock [J].
Annane, D ;
Sanquer, S ;
Sébille, V ;
Faye, A ;
Djuranovic, D ;
Raphaël, JC ;
Gajdos, P ;
Bellissant, E .
LANCET, 2000, 355 (9210) :1143-1148
[2]  
BABIOR BM, 1992, ADV ENZYMOL RAMB, V65, P49
[3]   MEASURING FOREARM BLOOD-FLOW AND INTERPRETING THE RESPONSES TO DRUGS AND MEDIATORS [J].
BENJAMIN, N ;
CALVER, A ;
COLLIER, J ;
ROBINSON, B ;
VALLANCE, P ;
WEBB, D .
HYPERTENSION, 1995, 25 (05) :918-923
[4]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[5]   Local venous responses tea endotoxin in humans [J].
Bhagat, K ;
Collier, J ;
Vallance, P .
CIRCULATION, 1996, 94 (03) :490-497
[6]   Downregulation of angiotensin II type I receptors during sepsis [J].
Bucher, M ;
Ittner, KP ;
Hobbhahn, J ;
Taeger, K ;
Kurtz, A .
HYPERTENSION, 2001, 38 (02) :177-182
[7]   Nitration of angiotensin II by •NO2 radicals and peroxynitrite -: •NO protects against •NO2 radical reaction [J].
Cudic, M ;
Dendane, M ;
Houé-Levin, C ;
Ducrocq, C .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 265 (03) :967-971
[8]  
Cuzzocrea S, 2001, PHARMACOL REV, V53, P135
[9]   Chemical modifications of the vasoconstrictor peptide angiotensin II by nitrogen oxides (NO, HNO2, HOONO) -: Evaluation by mass spectrometry [J].
Ducrocq, C ;
Dendane, M ;
Laprévote, O ;
Serani, L ;
Das, BC ;
Bouchemal-Chibani, N ;
Doan, BT ;
Gillet, B ;
Karim, A ;
Carayon, A ;
Payen, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 253 (01) :146-153
[10]   Arginine vasopressin in advanced vasodilatory shock -: A prospective, randomized, controlled study [J].
Dünser, MW ;
Mayr, AJ ;
Ulmer, H ;
Knotzer, H ;
Sumann, G ;
Pajk, W ;
Friesenecker, B ;
Hasibeder, WR .
CIRCULATION, 2003, 107 (18) :2313-2319